Evidence map›Paper›PMID 35806825›Full record

ArticleMaterials (Basel, Switzerland)2022

Simultaneous Substitution of Fe and Sr in Beta-Tricalcium Phosphate: Synthesis, Structural, Magnetic, Degradation, and Cell Adhesion Properties.

So-Min Kim, Kyung-Hyeon Yoo, Hyeonjin Kim, Yong-Il Kim, Seog-Young Yoon

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

So-Min KimDepartment of Materials Science and Engineering, Pusan National University, Busan 46241, Korea.ORCID 0000-0002-1673-5832
Kyung-Hyeon YooDepartment of Materials Science and Engineering, Pusan National University, Busan 46241, Korea.ORCID 0000-0001-5328-2919
Hyeonjin KimDepartment of Materials Science and Engineering, Pusan National University, Busan 46241, Korea.ORCID 0000-0001-6862-3907
Yong-Il KimDepartment of Orthodontics, Dental Research Institute, Pusan National University, Yansan 50612, Korea.ORCID 0000-0003-3889-2545
Seog-Young YoonDepartment of Materials Science and Engineering, Pusan National University, Busan 46241, Korea.ORCID 0000-0002-7882-3547
Pusan National University · KRPusan National University Dental Hospital · KR

Funding

National Research Foundation of Korea 2020R1A2C1014586
6 · The paper itself

Abstract

β-tricalcium phosphate is a promising bone graft substitute material with biocompatibility and high osteoinductivity. However, research on the ideal degradation and absorption for better clinical application remains a challenge. Now, we focus on modifying physicochemical properties and improving biological properties through essential ion co-substitution (Fe and Sr) in β-TCPs. Fe- and Sr-substituted and Fe/Sr co-substituted β-TCP were synthesized by aqueous co-precipitation with substitution levels ranging from 0.2 to 1.0 mol%. The β-TCP phase was detected by X-ray diffraction and Fourier transform infrared spectroscopy. Changes in Ca-O and P-O bond lengths of the co-substituted samples were observed through X-ray photoelectron spectroscopy. The results of VSM represent the M-H graph having a combination of diamagnetic and ferromagnetic properties. A TRIS-HCl solution immersion test showed that the degradation and resorption functions act synergistically on the surface of the co-substituted sample. Cell adhesion tests demonstrated that Fe enhances the initial adhesion and proliferation behavior of hDPSCs. The present work suggests that Fe and Sr co-substitution in β-TCP can be a candidate for promising bone graft materials in tissue engineering fields. In addition, the possibility of application of hyperthermia for cancer treatment can be expected.

Indexed as

beta-tricalcium phosphateco-substitutiondegradationmagnetic behavior

Identifiers

PMID35806825
PMCPMC9268321
OpenAlexW4283837916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.